A novel dopamine D3R agonist SK609 with norepinephrine transporter inhibition promotes improvement in cognitive task performance in rodent and non-human primate models of Parkinson's disease
Jay S. Schneider, Courtney A. Marshall, Lauren Keibel, Nathaniel W. Snyder, Michael P. Hill, Jonathan M. Brotchie, Tom H. Johnston, Barry D. Waterhouse, Sandhya Kortagere
Topics & Concepts
DopamineNeuroscienceParkinson's diseaseLevodopaPsychologyDopamine receptor D3Prefrontal cortexDopamine transporterStriatumNorepinephrine transporterMedicineNorepinephrineCognitionDopaminergicDiseaseInternal medicineParkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsNeuroscience and Neuropharmacology Research